These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 24931256)
21. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112 [TBL] [Abstract][Full Text] [Related]
22. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin. Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472 [TBL] [Abstract][Full Text] [Related]
23. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422 [TBL] [Abstract][Full Text] [Related]
24. MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. Zhang Y; Xu W; Ni P; Li A; Zhou J; Xu S Int J Biol Sci; 2016; 12(12):1437-1447. PubMed ID: 27994509 [TBL] [Abstract][Full Text] [Related]
25. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway. Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310 [TBL] [Abstract][Full Text] [Related]
26. miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells. Fang Y; Shen H; Li H; Cao Y; Qin R; Long L; Zhu X; Xie C; Xu W Acta Biochim Biophys Sin (Shanghai); 2013 Nov; 45(11):963-72. PubMed ID: 24108762 [TBL] [Abstract][Full Text] [Related]
27. miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB. Du Y; Zhu M; Zhou X; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T Tumour Biol; 2016 Jan; 37(1):1261-9. PubMed ID: 26286834 [TBL] [Abstract][Full Text] [Related]
28. RNAi knockdown of the Akt1 gene increases the chemosensitivity of gastric cancer cells to cisplatin both in vitro and in vivo. Zhou W; Fu XQ; Liu J; Yu HG Regul Pept; 2012 Jun; 176(1-3):13-21. PubMed ID: 22387880 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Zhang X; Huang L; Zhao Y; Tan W Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606 [TBL] [Abstract][Full Text] [Related]
30. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7. Zhou X; Jin W; Jia H; Yan J; Zhang G J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377 [TBL] [Abstract][Full Text] [Related]
31. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a. Cheng C; Qin Y; Zhi Q; Wang J; Qin C Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815 [TBL] [Abstract][Full Text] [Related]
32. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992 [TBL] [Abstract][Full Text] [Related]
33. Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy. Liu M; Yang Y; Liu D; Cao Y; Li Y J Tradit Chin Med; 2020 Dec; 40(6):908-916. PubMed ID: 33258341 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein. Wei X; Gao M; Ahmed Y; Gao M; Liu W; Zhang Y; Xie X; Zhao Q; Wang H; Gu K Oncol Lett; 2019 Aug; 18(2):1607-1616. PubMed ID: 31423228 [TBL] [Abstract][Full Text] [Related]
35. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP]. Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells. Wang M; Zhang R; Zhang S; Xu R; Yang Q Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930 [TBL] [Abstract][Full Text] [Related]
37. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a. Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881 [TBL] [Abstract][Full Text] [Related]
38. [Effect of antisense miR-224 on gastric cancer cell proliferation and apoptosis]. Mao S; He N; Xin L; Zeng F; Cao J Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):92-6. PubMed ID: 24796455 [TBL] [Abstract][Full Text] [Related]
39. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Yang SM; Huang C; Li XF; Yu MZ; He Y; Li J Toxicology; 2013 Apr; 306():162-8. PubMed ID: 23466500 [TBL] [Abstract][Full Text] [Related]
40. Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21. Wang Z; Ji F Oncol Lett; 2018 Apr; 15(4):4585-4591. PubMed ID: 29541229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]